- Operating profit and net income reached KRW47.4 billion and KRW38 billion, respectively; the company marked two consecutive quarters surpassing KRW100 billion in net sales

- Combined toxin and filler sales in the global Big Four markets – the US, China, Europe, and Brazil – accounted for 45% of total net sales

SEOUL, South Korea , Nov. 4, 2025 /PRNewswire/ -- Hugel Inc., a leading global medical aesthetics company publicly traded in South Korea, announced its consolidated financial results for the third quarter of 2025 on Tuesday. The company reported KRW105.9 billion in net sales, KRW47.4 billion in operating profit, and KRW38 billion in net income, maintaining strong profitability with a 77% gross profit and 45% operating profit.

The solid performance was driven by strong global sal

See Full Page